Venture Capital/Tech, consumer
Epiq Capital logo

Epiq Capital

Growth (Series C+) fund research profile

Epiq Capital is a growth-stage technology investor founded by Rishi Navani, with a focus on later-stage private companies rather than seed experimentation. The platform has backed Indian consumer, health, software and commerce businesses through primary and secondary transactions.

At a glance

Founded
2016
Footprint
Mumbai
Stage
Growth (Series C+)

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Epiq Capital uses a growth (series c+) approach across Tech, consumer.

Current evidence

Epiq’s current manager pages identify Lenskart, Zepto and GIVA among its growth-stage portfolio. Lenskart’s 2025 IPO prospectus records transfers from Epiq Capital B, providing a dated company-level outcome trail; current Fund III plans are not publicly disclosed.

Strategy

Growth (Series C+)

Sector focus

Tech, consumer

AIF structure context

Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.

Current signal

Epiq’s current manager pages identify Lenskart, Zepto and GIVA among its growth-stage portfolio. Lenskart’s 2025 IPO prospectus records transfers from Epiq Capital B, providing a dated company-level outcome trail; current Fund III plans are not publicly disclosed.

Investor questions

Epiq Capital research questions

What is Epiq Capital's investment strategy?

Epiq Capital is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Growth (Series C+), with a sector focus of Tech, consumer. The profile should be read with the linked source trail and Typical route: Category I AIF context.

What portfolio evidence is available for Epiq Capital?

The profile displays only company or asset names attributable to Epiq Capital in the reviewed public sources: Lenskart, Zepto, GIVA, Cult.fit, Pristyn Care, Dailyhunt, Park+. It does not represent a complete current portfolio unless the manager has published one.

What is known about Epiq Capital's performance or track record?

The second fund was reported at $225M and targeted about 10 companies with $20–25M tickets. Epiq has described portfolio revenue above $250M annualised and 75% annualised growth over three years; these are manager claims, not audited fund returns. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Epiq Capital's fund size, fees and minimum investment?

Public fund size: Fund I was reported at $100M and Fund II closed at $225M in 2023; Epiq said AUM exceeded $300M across two funds.. Public terms or access information: Growth equity, generally Series C and later, with primary and secondary transactions and reported $20–25M cheque sizes for Fund II.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Epiq Capital's investment team?

The current source record names Rishi Navani (ex-Matrix). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Epiq Capital?

Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Current vehicle terms, Fund III plans and fund-level performance are not publicly disclosed..

What is the latest public update on Epiq Capital?

2025-11: Epiq’s current manager pages identify Lenskart, Zepto and GIVA among its growth-stage portfolio. Lenskart’s 2025 IPO prospectus records transfers from Epiq Capital B, providing a dated company-level outcome trail; current Fund III plans are not publicly disclosed.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →